Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color

NCT03402893 is registered in ClinicalTrials.gov with Derm Research, PLLC as lead sponsor.

NCT NCT03402893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03402893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color
Lead sponsor
Derm Research, PLLC
Phase
Phase 4
Overall status
Completed
Start date
July 28, 2017
Completion date
February 28, 2018
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris, post inflammatory hyperpigmentation